世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000043034

2025〜2030年の北アメリカの分子診断市場(アメリカ・カナダ・メキシコ)- 2025年におけるサプライヤーシェア、国別の分析装置導入台数と戦略、2025〜2030年における感染症、遺伝子、がん、法医学、親子鑑定検査における数量と販売セグメント予測

VPGMarketResearch

2025-2030 North America Molecular Diagnostics Market in the US, Canada, Mexico--2025 Supplier Shares, Analyzer Installed Base and Strategies by Country, 2025-2030 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests

発刊日 2025/11/15

言語英語

体裁PDF

ライセンス/価格

0000043034

Local PDF
Global PDF

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

LeadingMarketResearch.com のこのデータベースは、感染症、遺伝性疾患、がん診断、法医学および親子鑑定アプリケーションに関する2024年のサプライヤーシェア、2024 〜 2028年の数量と売上予測、および主要な検査用の新技術や製品を開発または販売している企業の包括的なリストを提供します。

調査国

  • カナダ
  • メキシコ
  • アメリカ

主要企業

  • Abbott
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Cepheid/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Decode Genetics
  • Diasorin
  • 栄研化学(Eiken Chemical)
  • Elitech Group
  • Enzo Biochem
  • Exact Sciences
  • 富士レビオ(Fujirebio)
  • Grifols
  • Hologic/Gen-Probe
  • Illumina
  • LabCorp/Sequenom
  • Leica Biosystems/Kreatech
  • Li-Cor Biosciences
  • Myriad Genetics
  • Proteome Sciences
  • Qiagen
  • Quest Diagnostics
  • QuidelOrtho
  • Roche
  • 島津製作所(Shimadzu)
  • Siemens Healthineers
  • タカラバイオ(Takara Bio)
  • Tecan Group
  • Thermo Fisher

レポート詳細

図表

List of Tables
Canada
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Canada
Molecular Diagnostics Test Volume Forecasts by Application
Canada
Major Infectious Disease Test Volume Forecasts by Assay
Canada
Molecular Diagnostics Market Forecasts by Application
Canada
Major Infectious Disease Diagnostics Market Forecasts by Assay
Mexico
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Mexico
Molecular Diagnostics Test Volume Forecasts by Application
Mexico
Major Infectious Disease Test Volume Forecasts by Assay
Mexico
Molecular Diagnostics Market Forecasts by Application
Mexico
Major Infectious Disease Diagnostics Market Forecasts by Assay
U.S.A.
Molecular Diagnostics Test Volume and Sales by Major Application
U.S.A.
Laboratories Performing DNA Sequencing by Market Segment
U.S.A.
Echovirus Testing Market Estimated Sales by Major Supplier
U.S.A.
Enterovirus Testing Market Estimated Sales by Major Supplier
U.S.A.
EBV Testing Market Estimated Sales by Major Supplier
U.S.A.
Gonorrhea Testing Market Estimated Sales by Major Supplier
U.S.A.
Hepatitis Testing Market Estimated Sales by Major Supplier
U.S.A.
Hepatitis C Testing Market Estimated Sales by Major Supplier
U.S.A.
HIV/Hepatitis Blood Screening NAT
Market Reagent Sales by Major Supplier
U.S.A.
Herpes Testing Market Estimated Sales by Major Supplier
U.S.A.
Influenza Testing Market Estimated Sales by Major Supplier
U.S.A.
Meningitis Testing Market Estimated Sales by Major Supplier
U.S.A.
Mycoplasma Testing Market Estimated Sales by Major Supplier
U.S.A.
Pneumonia Testing Market Estimated Sales by Major Supplier
U.S.A.
Rabies Testing Market Estimated Sales by Major Supplier
U.S.A.
RSV Testing Market Estimated Sales by Major Supplier
U.S.A.
Salmonella Testing Market Estimated Sales by Major Supplier
U.S.A.
Shigella Testing Market Estimated Sales by Major Supplier
U.S.A.
West Nile Virus Nat Market Reagent Sales by Major Supplier
Major Companies Developing or Marketing AIDS Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Bartonella
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Candida
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Clostridium
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Coronavirus
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Cryptosporidium
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hantavirus
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Helicobacter
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Herpes
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Influenza
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Legionella
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Lyme
Disease Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Measles
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Meningitis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mononucleosis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mumps
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing RSV
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rotavirus
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rubella
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Septicemia
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Shigella
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Syphilis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Trichomonas
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis
Molecular Diagnostic and Other Direct Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer
Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular
Diagnostic Tests for Genetic Diseases

この商品のレポートナンバー

0000043034

最近見たレポート

バイオプロセスろ過:世界市場

Bioprocess Filtration: Global Markets

2025/10/01

4,650 USD

2025〜2030年の世界の分子診断市場(92カ国):2025年におけるサプライヤーシェア、国別の分析装置導入台数と戦略、2025〜2030年における感染症、遺伝子、がん、法医学、親子鑑定検査における数量と販売セグメント予測

2025-2030 World Molecular Diagnostics Market in 92 Countries: 2025 Supplier Shares, Analyzer Installed Base and Strategies by Country, 2025-2030 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests

2025/11/15

24,500 USD

2025〜2030年のインドの分子診断市場 - 2025年におけるサプライヤーシェア、国別の分析装置導入台数と戦略、2025〜2030年における感染症、遺伝子、がん、法医学、親子鑑定検査における数量と販売セグメント予測

2025-2030 India Molecular Diagnostics Market: 2025 Supplier Shares, Analyzer Installed Base and Strategies, 2025-2030 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests

2025/11/15

1,150 USD

2025〜2030年のシンガポールの分子診断市場 - 2025年におけるサプライヤーシェア、国別の分析装置導入台数と戦略、2025〜2030年における感染症、遺伝子、がん、法医学、親子鑑定検査における数量と販売セグメント予測

2025-2030 Singapore Molecular Diagnostics Market: 2025 Supplier Shares, Analyzer Installed Base and Strategies, 2025-2030 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests

2025/11/15

1,150 USD

世界の患者モニタリングデバイス市場規模、トレンド、機会分析レポート ― 製品別(血糖モニタリングシステム、心臓モニタリングデバイス、呼吸モニタリングデバイス、マルチパラメータモニタリングデバイス、温度モニタリングデバイス、血行動態/圧力モニタリングデバイス、胎児および新生児モニタリングデバイス、神経モニタリングデバイス、ウェアラブル薬物送達システム、体重モニタリングデバイス、その他の患者モニタリングデバイス)、最終用途別(病院、外来手術センター、在宅ケア施設、その他のエンドユーザー)、および予測(2024〜2035年)

Global Patient Monitoring Devices Market Size, Trend & Opportunity Analysis Report, by Product (Blood Glucose Monitoring Systems, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Multi-Parameter Monitoring Devices, Temperature Monitoring Devices, Hemodynamic/Pressure Monitoring Devices, Fetal & Neonatal Monitoring Devices, Neuromonitoring Devices, Wearable Drug Delivery Systems, Weight Monitoring Devices, Other Patient Monitoring Devices), End Use (Hospitals, Ambulatory Surgery Centres, Home Care Settings, Other End Users), and Forecast, 2024-2035

2025/11/25

2,950 USD

世界の臓器チップ(Organ-on-a-Chip)市場規模、トレンド、機会分析レポート ― 製品・サービス別(機器、臓器チップデバイス、サービス)、用途別(創薬、毒性研究、その他)、最終用途別(製薬・バイオテクノロジー企業、学術・研究機関、その他)、および予測(2025〜2035年)

Global Organ-on-Chip Market Size, Trend & Opportunity Analysis Report, by Product & Service (Instruments, Organ-on-a-Chip Devices, Services), Application (Drug Discovery, Toxicology Research, Others), End Use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others), and Forecast, 2025-2035

2025/11/25

2,950 USD

TOP